These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20390540)

  • 21. Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection.
    Baigent SJ; Smith LP; Nair VK; Currie RJ
    Vet Immunol Immunopathol; 2006 Jul; 112(1-2):78-86. PubMed ID: 16682084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of various Marek's disease vaccines protocols for prevention of Marek's disease virus-induced immunosuppression.
    Faiz NM; Cortes AL; Guy JS; Fogle JE; Gimeno IM
    Vaccine; 2016 Jul; 34(35):4180-4187. PubMed ID: 27371103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective efficacy of Marek's disease virus (MDV) CVI-988 CEF65 clone C against challenge infection with three very virulent MDV strains.
    de Boer GF; Groenendal JE; Boerrigter HM; Kok GL; Pol JM
    Avian Dis; 1986; 30(2):276-83. PubMed ID: 3015113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Embryo vaccination against Marek's disease with serotypes 1, 2 and 3 vaccines administered singly or in combination.
    Sharma JM; Witter RL
    Avian Dis; 1983; 27(2):453-63. PubMed ID: 6307248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Protective immunity of a meq-deleted Marek's disease virus against very virulent virus challenge in chickens].
    Su S; Li Y; Sun A; Zhao P; Ding J; Zhu H; Cui Z
    Wei Sheng Wu Xue Bao; 2010 Mar; 50(3):380-6. PubMed ID: 20499644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between Marek's disease virus load in peripheral blood lymphocytes at various stages of infection and clinical Marek's disease in broiler chickens.
    Islam AF; Walkden-Brown SW; Islam A; Underwood GJ; Groves PJ
    Avian Pathol; 2006 Feb; 35(1):42-8. PubMed ID: 16448942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of a combination vaccine containing MDV CVI 988 strain and HVT against challenge with very virulent MDV.
    Geerligs HJ; Weststrate MW; Pertile TL; Rodenberg J; Kumar M; Chu S
    Acta Virol; 1999; 43(2-3):198-200. PubMed ID: 10696445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination against Marek's disease reduces telomerase activity and viral gene transcription in peripheral blood leukocytes from challenged chickens.
    Debba-Pavard M; Ait-Lounis A; Soubieux D; Rasschaert D; Dambrine G
    Vaccine; 2008 Sep; 26(38):4904-12. PubMed ID: 18680776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Avian influenza adenovirus-vectored in ovo vaccination: target embryo tissues and combination with Marek's disease vaccine.
    Breedlove C; Minc JK; Tang DC; van Santen VL; van Ginkel FW; Toro H
    Avian Dis; 2011 Dec; 55(4):667-73. PubMed ID: 22312988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the Protection Efficacy of a Serotype 1 Marek's Disease Virus-Vectored Bivalent Vaccine Against Infectious Laryngotracheitis and Marek's Disease.
    Gimeno IM; Cortes AL; Faiz NM; Hernandez-Ortiz BA; Guy JS; Hunt HD; Silva RF
    Avian Dis; 2015 Jun; 59(2):255-62. PubMed ID: 26473676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection provided by Rispens CVI988 vaccine against Marek's disease virus isolates of different pathotypes and early prediction of vaccine take and MD outcome.
    Ralapanawe S; Walkden-Brown SW; Renz KG; Islam AF
    Avian Pathol; 2016; 45(1):26-37. PubMed ID: 26503904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.
    Shamblin CE; Greene N; Arumugaswami V; Dienglewicz RL; Parcells MS
    Vet Microbiol; 2004 Sep; 102(3-4):147-67. PubMed ID: 15327791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of an infectious Marek's disease virus bacterial artificial chromosome and characterization of protection induced in chickens.
    Cui HY; Wang YF; Shi XM; An TQ; Tong GZ; Lan DS; He L; Liu CJ; Wang M
    J Virol Methods; 2009 Mar; 156(1-2):66-72. PubMed ID: 19026690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viral kinetics, shedding profile, and transmission of serotype 1 Marek's disease vaccine Rispens/CVI988 in maternal antibody-free chickens.
    Islam T; Renz KG; Walkden-Brown SW; Ralapanawe S
    Avian Dis; 2013 Jun; 57(2 Suppl):454-63. PubMed ID: 23901761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant Marek's disease virus (MDV) lacking the Meq oncogene confers protection against challenge with a very virulent plus strain of MDV.
    Lee LF; Lupiani B; Silva RF; Kung HJ; Reddy SM
    Vaccine; 2008 Mar; 26(15):1887-92. PubMed ID: 18313812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens.
    Geerligs H; Quanz S; Suurland B; Spijkers IE; Rodenberg J; Davelaar FG; Jongsma B; Kumar M
    Vaccine; 2008 Oct; 26(44):5595-600. PubMed ID: 18706949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A recombinant field strain of Marek's disease (MD) virus with reticuloendotheliosis virus long terminal repeat insert lacking the meq gene as a vaccine against MD.
    Su S; Cui N; Zhou Y; Chen Z; Li Y; Ding J; Wang Y; Duan L; Cui Z
    Vaccine; 2015 Jan; 33(5):596-603. PubMed ID: 25562789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility of adult chickens, with and without prior vaccination, to challenge with Marek's disease virus.
    Witter RL; Gimeno IM
    Avian Dis; 2006 Sep; 50(3):354-65. PubMed ID: 17039834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection and differentiation of CVI988 (Rispens vaccine) from other serotype 1 Marek's disease viruses.
    Gimeno IM; Dunn JR; Cortes AL; El-Gohary Ael-G; Silva RF
    Avian Dis; 2014 Jun; 58(2):232-43. PubMed ID: 25055627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A toll-like receptor 3 ligand enhances protective effects of vaccination against Marek's disease virus and hinders tumor development in chickens.
    Parvizi P; Mallick AI; Haq K; Haghighi HR; Orouji S; Thanthrige-Don N; St Paul M; Brisbin JT; Read LR; Behboudi S; Sharif S
    Viral Immunol; 2012 Oct; 25(5):394-401. PubMed ID: 22857262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.